These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37498374)

  • 1. Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways.
    Awad AM; Elshaer SL; Gangaraju R; Abdelaziz RR; Nader MA
    Inflammopharmacology; 2024 Feb; 32(1):495-508. PubMed ID: 37498374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice.
    Wang J; Wang L; Zhou J; Qin A; Chen Z
    Biomed Pharmacother; 2018 Oct; 106():1250-1257. PubMed ID: 30119194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α.
    Aboismaiel MG; Amin MN; Eissa LA
    Biol Res; 2024 Jul; 57(1):47. PubMed ID: 39033184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; An insight.
    Yosri H; El-Kashef DH; El-Sherbiny M; Said E; Salem HA
    Biomed Pharmacother; 2022 Nov; 155():113758. PubMed ID: 36271546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M; Gao J; Jiang L; Dai Y
    Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling.
    Abd El-Khalik SR; Nasif E; Arakeep HM; Rabah H
    Biol Trace Elem Res; 2022 Apr; 200(4):1677-1687. PubMed ID: 34241775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L; Han J; Yuan R; Xue L; Pang W
    Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation.
    Awad AM; Elshaer SL; Gangaraju R; Abdelaziz RR; Nader MA
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111127. PubMed ID: 37907048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
    Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
    J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy.
    Abd El-Baset SA; Mazen NF; Abdul-Maksoud RS; Kattaia AAA
    Tissue Barriers; 2023 Jan; 11(1):2069966. PubMed ID: 35504734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
    Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
    Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
    Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
    Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of PKC/TLR-4/NF-kB signaling by sulbutiamine improves diabetic nephropathy in rats.
    Ghaiad HR; Ali SO; Al-Mokaddem AK; Abdelmonem M
    Chem Biol Interact; 2023 Aug; 381():110544. PubMed ID: 37224990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
    Yin Y; Chen F; Wang W; Wang H; Zhang X
    Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hong Guo Ginseng Guo (HGGG) protects against kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome and regulating intestinal flora.
    Pan S; Jiang SS; Li R; Tian B; Huang CY; Wang R; Li YY; Zhu H; Yuan YF; Hu X
    Phytomedicine; 2024 Sep; 132():155861. PubMed ID: 39024672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells ameliorated kidney fibrosis by attenuating TLR4/NF-κB in diabetic rats.
    Lin L; Lin H; Wang D; Bao Z; Cai H; Zhang X
    Life Sci; 2020 Dec; 262():118385. PubMed ID: 32926926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome.
    Sun Y; Liu Y; Guan X; Kang J; Wang X; Liu Q; Li D; Xu H; Tao Z; Deng Y
    IUBMB Life; 2020 May; 72(5):1065-1074. PubMed ID: 32083808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.